238 related articles for article (PubMed ID: 18607344)
1. Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.
Qiu J; Ai L; Ramachandran C; Yao B; Gopalakrishnan S; Fields CR; Delmas AL; Dyer LM; Melnick SJ; Yachnis AT; Schwartz PH; Fine HA; Brown KD; Robertson KD
Lab Invest; 2008 Sep; 88(9):910-25. PubMed ID: 18607344
[TBL] [Abstract][Full Text] [Related]
2. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
Rivenbark AG; Livasy CA; Boyd CE; Keppler D; Coleman WB
Exp Mol Pathol; 2007 Oct; 83(2):188-97. PubMed ID: 17540367
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.
Ai L; Kim WJ; Kim TY; Fields CR; Massoll NA; Robertson KD; Brown KD
Cancer Res; 2006 Aug; 66(16):7899-909. PubMed ID: 16912163
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.
Rivenbark AG; Jones WD; Coleman WB
Lab Invest; 2006 Dec; 86(12):1233-42. PubMed ID: 17043665
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
Pulukuri SM; Gorantla B; Knost JA; Rao JS
Oncogene; 2009 Aug; 28(31):2829-38. PubMed ID: 19503093
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.
Restrepo A; Smith CA; Agnihotri S; Shekarforoush M; Kongkham PN; Seol HJ; Northcott P; Rutka JT
Neuro Oncol; 2011 Jan; 13(1):42-50. PubMed ID: 21075782
[TBL] [Abstract][Full Text] [Related]
8. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of cystatin M in breast carcinoma.
Schagdarsurengin U; Pfeifer GP; Dammann R
Oncogene; 2007 May; 26(21):3089-94. PubMed ID: 17099723
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.
Vladimirova V; Mikeska T; Waha A; Soerensen N; Xu J; Reynolds PC; Pietsch T
Neoplasia; 2009 Jul; 11(7):700-11. PubMed ID: 19568415
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer.
Veena MS; Lee G; Keppler D; Mendonca MS; Redpath JL; Stanbridge EJ; Wilczynski SP; Srivatsan ES
Genes Chromosomes Cancer; 2008 Sep; 47(9):740-54. PubMed ID: 18506750
[TBL] [Abstract][Full Text] [Related]
12. The human cystatin M/E gene (CST6): exclusion candidate gene for harlequin ichthyosis.
Zeeuwen PL; Dale BA; de Jongh GJ; van Vlijmen-Willems IM; Fleckman P; Kimball JR; Stephens K; Schalkwijk J
J Invest Dermatol; 2003 Jul; 121(1):65-8. PubMed ID: 12839564
[TBL] [Abstract][Full Text] [Related]
13. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea.
Zeeuwen PL; van Vlijmen-Willems IM; Cheng T; Rodijk-Olthuis D; Hitomi K; Hara-Nishimura I; John S; Smyth N; Reinheckel T; Hendriks WJ; Schalkwijk J
FASEB J; 2010 Oct; 24(10):3744-55. PubMed ID: 20495178
[TBL] [Abstract][Full Text] [Related]
14. Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis.
Chukkapalli S; Amessou M; Dekhil H; Dilly AK; Liu Q; Bandyopadhyay S; Thomas RD; Bejna A; Batist G; Kandouz M
Carcinogenesis; 2014 Apr; 35(4):877-85. PubMed ID: 24306026
[TBL] [Abstract][Full Text] [Related]
15. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J
Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth.
Hosokawa M; Kashiwaya K; Eguchi H; Ohigashi H; Ishikawa O; Furihata M; Shinomura Y; Imai K; Nakamura Y; Nakagawa H
Cancer Sci; 2008 Aug; 99(8):1626-32. PubMed ID: 18754876
[TBL] [Abstract][Full Text] [Related]
17. The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin.
Song J; Jie C; Polk P; Shridhar R; Clair T; Zhang J; Yin L; Keppler D
Biochem Biophys Res Commun; 2006 Feb; 340(1):175-82. PubMed ID: 16356477
[TBL] [Abstract][Full Text] [Related]
18. The transglutaminase 2 gene is aberrantly hypermethylated in glioma.
Dyer LM; Schooler KP; Ai L; Klop C; Qiu J; Robertson KD; Brown KD
J Neurooncol; 2011 Feb; 101(3):429-40. PubMed ID: 20596752
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.
Chimonidou M; Strati A; Tzitzira A; Sotiropoulou G; Malamos N; Georgoulias V; Lianidou ES
Clin Chem; 2011 Aug; 57(8):1169-77. PubMed ID: 21700955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
